Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 19 | 2024 | 1188 | 5.780 |
Why?
|
| Heart-Assist Devices | 9 | 2024 | 759 | 2.640 |
Why?
|
| Shock, Cardiogenic | 5 | 2024 | 106 | 2.030 |
Why?
|
| Cardiotonic Agents | 2 | 2024 | 89 | 1.740 |
Why?
|
| Hemodynamics | 11 | 2024 | 731 | 1.310 |
Why?
|
| Natriuresis | 1 | 2024 | 29 | 0.950 |
Why?
|
| Diuretics | 1 | 2024 | 75 | 0.910 |
Why?
|
| Veterans | 1 | 2024 | 85 | 0.860 |
Why?
|
| Spironolactone | 1 | 2021 | 12 | 0.780 |
Why?
|
| Cardiac Catheterization | 4 | 2024 | 303 | 0.740 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2020 | 22 | 0.710 |
Why?
|
| Blood Pressure | 1 | 2024 | 901 | 0.700 |
Why?
|
| Defibrillators, Implantable | 2 | 2021 | 145 | 0.700 |
Why?
|
| Sex Factors | 1 | 2023 | 1069 | 0.690 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 265 | 0.650 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 126 | 0.650 |
Why?
|
| HIV | 1 | 2018 | 48 | 0.610 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 53 | 0.600 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 73 | 0.590 |
Why?
|
| Bundle-Branch Block | 1 | 2017 | 55 | 0.570 |
Why?
|
| Pacemaker, Artificial | 1 | 2018 | 96 | 0.570 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2017 | 69 | 0.550 |
Why?
|
| Heart Atria | 1 | 2018 | 281 | 0.530 |
Why?
|
| Health Status | 1 | 2018 | 371 | 0.520 |
Why?
|
| Humans | 29 | 2024 | 89581 | 0.500 |
Why?
|
| Pulmonary Wedge Pressure | 4 | 2024 | 113 | 0.480 |
Why?
|
| Heart Transplantation | 4 | 2024 | 717 | 0.470 |
Why?
|
| Cardiac Output | 3 | 2022 | 155 | 0.440 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 357 | 0.430 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2023 | 132 | 0.400 |
Why?
|
| HIV Infections | 1 | 2018 | 844 | 0.330 |
Why?
|
| Global Health | 2 | 2018 | 191 | 0.270 |
Why?
|
| Treatment Outcome | 5 | 2024 | 8268 | 0.270 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2023 | 78 | 0.240 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 24 | 0.240 |
Why?
|
| Prognosis | 5 | 2024 | 3792 | 0.240 |
Why?
|
| Male | 11 | 2024 | 42521 | 0.230 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2024 | 31 | 0.230 |
Why?
|
| United States | 4 | 2024 | 7013 | 0.230 |
Why?
|
| Ventricular Function, Left | 3 | 2024 | 607 | 0.220 |
Why?
|
| Reference Standards | 1 | 2023 | 144 | 0.210 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 98 | 0.210 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 115 | 0.200 |
Why?
|
| American Heart Association | 1 | 2022 | 95 | 0.200 |
Why?
|
| Heart Ventricles | 2 | 2024 | 779 | 0.200 |
Why?
|
| Acute Disease | 1 | 2024 | 842 | 0.200 |
Why?
|
| Atrial Pressure | 1 | 2021 | 6 | 0.200 |
Why?
|
| Stroke Volume | 2 | 2021 | 465 | 0.200 |
Why?
|
| Mucormycosis | 1 | 2021 | 15 | 0.200 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2021 | 17 | 0.190 |
Why?
|
| Retrospective Studies | 7 | 2024 | 9085 | 0.190 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2021 | 24 | 0.190 |
Why?
|
| Torsion, Mechanical | 1 | 2020 | 6 | 0.180 |
Why?
|
| Troponin T | 1 | 2020 | 39 | 0.180 |
Why?
|
| Middle Aged | 8 | 2024 | 26049 | 0.180 |
Why?
|
| Female | 9 | 2024 | 46333 | 0.180 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2023 | 183 | 0.170 |
Why?
|
| Registries | 1 | 2024 | 789 | 0.170 |
Why?
|
| Tissue and Organ Procurement | 1 | 2024 | 348 | 0.170 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2021 | 113 | 0.170 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 319 | 0.160 |
Why?
|
| Risk Factors | 4 | 2024 | 5505 | 0.150 |
Why?
|
| Reoperation | 1 | 2020 | 602 | 0.150 |
Why?
|
| Predictive Value of Tests | 4 | 2024 | 1728 | 0.150 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 236 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2018 | 120 | 0.140 |
Why?
|
| Treatment Failure | 1 | 2017 | 285 | 0.140 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 162 | 0.140 |
Why?
|
| Adult | 5 | 2024 | 26680 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2017 | 497 | 0.120 |
Why?
|
| Prevalence | 1 | 2018 | 1245 | 0.110 |
Why?
|
| Biomarkers | 1 | 2020 | 1770 | 0.110 |
Why?
|
| Aged | 5 | 2024 | 19221 | 0.110 |
Why?
|
| Antifibrinolytic Agents | 1 | 2014 | 39 | 0.110 |
Why?
|
| Tranexamic Acid | 1 | 2014 | 37 | 0.110 |
Why?
|
| Incidence | 1 | 2018 | 1597 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2014 | 169 | 0.110 |
Why?
|
| Echocardiography | 1 | 2018 | 938 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2014 | 114 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2024 | 2306 | 0.090 |
Why?
|
| Memory | 1 | 2012 | 220 | 0.090 |
Why?
|
| Anxiety | 1 | 2012 | 311 | 0.090 |
Why?
|
| Heart | 2 | 2024 | 574 | 0.090 |
Why?
|
| Motivation | 1 | 2012 | 296 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2012 | 378 | 0.080 |
Why?
|
| Clinical Laboratory Services | 1 | 2024 | 4 | 0.060 |
Why?
|
| Bilirubin | 1 | 2024 | 131 | 0.060 |
Why?
|
| Ventricular Function, Right | 1 | 2024 | 146 | 0.050 |
Why?
|
| Health Care Rationing | 1 | 2024 | 83 | 0.050 |
Why?
|
| Thorax | 1 | 2023 | 77 | 0.050 |
Why?
|
| Amphotericin B | 1 | 2021 | 34 | 0.050 |
Why?
|
| Waiting Lists | 1 | 2023 | 184 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2021 | 38 | 0.050 |
Why?
|
| Aortic Valve | 1 | 2023 | 244 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2021 | 122 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 142 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2021 | 97 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2021 | 388 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 300 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2017 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 5344 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 775 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 115 | 0.030 |
Why?
|
| Electroshock | 1 | 2012 | 17 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 49 | 0.030 |
Why?
|
| Conditioning, Classical | 1 | 2012 | 36 | 0.030 |
Why?
|
| Odorants | 1 | 2012 | 70 | 0.030 |
Why?
|
| Fear | 1 | 2012 | 79 | 0.030 |
Why?
|
| Sexual Behavior, Animal | 1 | 2012 | 95 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 1720 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6829 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 4043 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 4310 | 0.020 |
Why?
|
| Animals | 1 | 2012 | 27420 | 0.010 |
Why?
|